figshare
Browse
12933_2021_1228_MOESM1_ESM.docx (20.46 kB)

Additional file 1 of A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study

Download (20.46 kB)
journal contribution
posted on 2021-02-03, 04:31 authored by Shigenori Hiruma, Fumika Shigiyama, Shinji Hisatake, Sunao Mizumura, Nobuyuki Shiraga, Masaaki Hori, Takanori Ikeda, Takahisa Hirose, Naoki Kumashiro
Additional file 1. Additional patient parameters (physical and biochemical parameters that showed no significant differences between the empagliflozin and sitagliptin groups).

Funding

Boehringer Ingelheim Eli Lilly Japan

History

Usage metrics

    Cardiovascular Diabetology

    Categories

    Keywords

    DPP-4 inhibitorEarly-stage type 2 diabetes mellitusEpicardial fat123I-BMIPP scintigraphyMyocardial triglyceride contentPericardial fatPreserved cardiac functionSGLT2 inhibitor

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC